These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12911161)

  • 1. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients.
    Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients.
    Kang DH; Yoon KI; Han DS
    Nephrol Dial Transplant; 1998 Nov; 13(11):2877-83. PubMed ID: 9829494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
    Carlini R; Obialo CI; Rothstein M
    Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis.
    Stefanidis I; Mertens PR; Wurth P; Bach R; Makropoulos W; Mann H; Heintz B
    Int J Artif Organs; 2001 Jun; 24(6):367-73. PubMed ID: 11482502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients.
    Takayama K; Nagai T; Kinugasa E; Akizawa T; Koshikawa S
    ASAIO Trans; 1991; 37(3):M187-8. PubMed ID: 1836334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic changes in nitric oxide generation in hemodialyzed patients with end-stage renal disease treated with recombinant human erythropoietin.
    Kang ES; Wang YB; Cardenas R; Tevlin MT; Mishra S; Acchiardo SR
    Am J Med Sci; 2000 Mar; 319(3):149-57. PubMed ID: 10746825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients.
    Miyashita K; Tojo A; Kimura K; Goto A; Omata M; Nishiyama K; Fujita T
    Hypertens Res; 2004 Feb; 27(2):79-84. PubMed ID: 15005270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
    Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids.
    Bode-Böger SM; Böger RH; Kuhn M; Radermacher J; Frölich JC
    Kidney Int; 1996 Oct; 50(4):1255-61. PubMed ID: 8887285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin ameliorated endothelial dysfunction and macrophage infiltration by increasing nitric oxide in hypertensive 5/6 nephrectomized rat aorta.
    Toba H; Morishita M; Tojo C; Nakano A; Oshima Y; Kojima Y; Yoshida M; Nakashima K; Wang J; Kobara M; Nakata T
    Eur J Pharmacol; 2011 Apr; 656(1-3):81-7. PubMed ID: 21296066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lui SF; Leung JC; Law E; Nicholls MG
    Nephron; 1991; 57(4):394-400. PubMed ID: 1828543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension.
    Kohno M; Yokokawa K; Minami M; Yasunari K; Maeda K; Kano H; Hanehira T; Yoshikawa J
    Metabolism; 1999 Oct; 48(10):1256-9. PubMed ID: 10535387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of vasoactive substances in chronic renal failure.
    Cantaro S; Milan Manani S; Marcon R; Bonfante L; Masiero M; D'Angelo A; Calò L
    Clin Nephrol; 2001 May; 55(5):393-9. PubMed ID: 11393385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased nitric oxide in women with essential hypertension in prehypertensive phase.
    Gerasimovska-Kitanovska B; Zafirovska K; Bogdanovska S; Lozance L; Severova-Andreevska G
    Croat Med J; 2005 Dec; 46(6):889-93. PubMed ID: 16342341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effect of low initial dose and gradual increase of erythropoietin treatment in hemodialysis patients.
    Walter J; Gål J; Taraba I
    Artif Organs; 1995 Jan; 19(1):76-80. PubMed ID: 7741644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].
    Müller R; Steffen HM; Brunner R; Pollok M; Baldamus CA; Kaufmann W
    Klin Wochenschr; 1991 Oct; 69(16):742-8. PubMed ID: 1662322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of effective component from "qing kai ling" on endothelial cell of microvessel in MCAO rats].
    Xu L; Ma S; Li P; Tang Q
    Zhong Yao Cai; 2004 May; 27(5):348-51. PubMed ID: 15376390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
    Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L
    Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and blood vessel endothelin-1 concentrations in hypertensive uremic rats treated with erythropoietin.
    Lebel M; Lacasse-M S; Larivière R; Kingma I; Grose JH
    Clin Exp Hypertens; 1998 Nov; 20(8):939-51. PubMed ID: 9817611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.